SRS Performance — ProShares UltraShort Real Estate
Data updated: 2026-08-14
SRS returned −15.71% year to date and −11.01% over one year to May 2026. Annualised returns are −14.53% over 3 years and −7.24% over 5 years. The fund trailed its Trading - Leveraged category average: $100 invested three years ago grew to $62, against $173 for the category, and to $89 over one year, against $137. Volatility over the past three years was 33.55% a year. In the 12 months to May 2026 the fund lost a net $2.3M, and assets reached $16.87M.
SRS Growth of $100
What $100 invested in ProShares UltraShort Real Estate grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | SRS | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $89 | $137 |
| 3 years (Jun 2023 – May 2026) | $62 | $173 |
| 5 years (Jun 2021 – May 2026) | $69 | $155 |
| Since data start (Sep 2019 – May 2026) | $31 | $181 |
SRS Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | −15.71% |
| 1 year | −11.01% |
| 3 years (annualised) | −14.53% |
| 5 years (annualised) | −7.24% |
SRS Annual Returns
Calendar-year total returns of ProShares UltraShort Real Estate, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | −15.71% |
| 2025 | −1.62% |
| 2024 | −3.57% |
| 2023 | −18.81% |
| 2022 | +54.33% |
| 2021 | −52.03% |
| 2020 | −33.13% |
| 2019 (Sep–Dec) | −4.72% |
SRS Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −4.8% | −10.4% | +13.9% | −15.3% | +2.4% | — | — | — | — | — | — | — |
| 2025 | −3.4% | −7.3% | +5.1% | +0.5% | −1.4% | +0.3% | +0.7% | −3.5% | −0.2% | +6.8% | −3.1% | +5.0% |
| 2024 | +10.7% | −4.6% | −2.7% | +19.6% | −8.9% | −3.0% | −12.4% | −10.2% | −5.5% | +7.5% | −7.4% | +19.9% |
| 2023 | −17.8% | +13.4% | +2.9% | −1.5% | +10.1% | −9.8% | −1.8% | +7.2% | +16.7% | +5.6% | −21.3% | −15.3% |
| 2022 | +17.6% | +8.5% | −12.9% | +6.9% | +7.2% | +13.0% | −16.2% | +12.1% | +29.4% | −7.7% | −13.3% | +10.2% |
| 2021 | −0.2% | −4.9% | −11.2% | −14.7% | −2.6% | −5.0% | −9.4% | −4.3% | +11.6% | −13.3% | +4.0% | −17.3% |
| 2020 | −3.0% | +14.2% | +18.1% | −23.0% | −6.9% | −8.4% | −8.8% | −1.1% | +3.0% | +5.1% | −15.7% | −5.5% |
| 2019 | — | — | — | — | — | — | — | — | −3.5% | −1.4% | +2.1% | −1.9% |
SRS Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 33.55%
- 3-year Sharpe ratio: -0.57 (vs 4.5% risk-free rate)
- Best month: +19.91% (Dec 2024)
- Worst month: −21.25% (Nov 2023)
SRS Fund Flows
Monthly money in and out of ProShares UltraShort Real Estate, from SEC Form N-PORT.
- 12-month net flow: −$2.3M
- 12-month gross sales (incl. reinvestments): $5.7M
- Sales ÷ redemptions: 0.72×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $406K | −$406K |
| Apr 2026 | $0 | $0 | $0 |
| Mar 2026 | $0 | $0 | $0 |
| Feb 2026 | $469K | $439K | $30K |
| Jan 2026 | $491K | $1.4M | −$912K |
| Dec 2025 | $0 | $489K | −$489K |
| Nov 2025 | $471K | $0 | $471K |
| Oct 2025 | $1.9M | $2.8M | −$961K |
| Sep 2025 | $946K | $466K | $480K |
| Aug 2025 | $477K | $1.4M | −$954K |
| Jul 2025 | $955K | $470K | $485K |
| Jun 2025 | $0 | $0 | $0 |
SRS Assets Under Management
Net assets of ProShares UltraShort Real Estate by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $16.87M |
| 2026-02-28 | $17.59M |
| 2025-11-30 | $21.22M |
| 2025-08-31 | $20.75M |
| 2025-05-31 | $21.98M |
| 2025-02-28 | $22.25M |
| 2024-11-30 | $23.73M |
| 2024-08-31 | $28.30M |
| 2024-05-31 | $41.21M |
| 2024-02-29 | $40.35M |
| 2023-11-30 | $47.91M |
| 2023-08-31 | $59.16M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.